greeksoup/ stock research
Stock research / United States / CYTK / 13F holders

Cytokinetics Inc. 13F holders

Of the 44 funds followed here, 9 reported a position in Cytokinetics Inc. in a 13F for the quarter ended 30 June 2026. The largest: FMR LLC, 5.0 million shares worth $428.7 million, 0.0% of its reported book.

FundSharesValueOf its bookChange on the quarterStatusQuarter endedFiling
FMR LLC5,031,782$428.7 million0.0%-5,691,358trimmed30 June 202613F
Geode Capital Management3,712,501$316.3 million0.0%+497,086added30 June 202613F
Citadel Advisors1,966,745$167.5 million0.0%+412,387added30 June 202613F
Capital Research Global Investors1,686,625$143.7 million0.0%+915,626added30 June 202613F
Point72 Asset Management1,588,312$135.3 million0.1%+927,310added30 June 202613F
Norges Bank1,015,522$86.5 million0.0%held30 June 202613F
Two Sigma Investments317,411$27.0 million0.0%+32,403added30 June 202613F
Alyeska250,000$21.3 million0.1%+100,000added30 June 202613F
Millennium Management209,817$17.9 million0.0%-117,042trimmed30 June 202613F
Value is what the fund reported.
Read moreChange is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.

Schedule 13D and 13G filed on the name, last twelve months

FiledScheduleWhoHoldingOf the classEvent dateRule or purposeFiling
13 August 202613G/AWellington Management Group LLP and 5 others7.1 million5.1%30 June 2026passive, institutional (13d-1(b))EDGAR
8 July 202613G/AFmr Llc and 3 others5.2 million3.9%30 June 2026passive, institutional (13d-1(b))EDGAR
6 May 202613G/AFmr Llc and 3 others11.1 million9.0%31 March 2026passive, institutional (13d-1(b))EDGAR
29 April 202613GVanguard Capital Management and 1 other6.4 million5.2%31 March 2026passive, institutional (13d-1(b))EDGAR
26 March 202613G/AThe Vanguard Group and 1 other00.0%13 March 2026passive, institutional (13d-1(b))EDGAR
17 February 202613G/AT. Rowe Price Investment Management, Inc. and 1 other17.7 million14.5%31 December 2025passive, institutional (13d-1(b))EDGAR
14 November 202513G/AT. Rowe Price Investment Management, Inc. and 1 other19.1 million16.0%30 September 2025passive, institutional (13d-1(b))EDGAR
10 November 202513GState Street Corporation and 1 other5.6 million4.7%30 September 2025passive, institutional (13d-1(b))EDGAR
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read moreAmendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.

Fails to deliver

Settlement dateShares failedPriceFile
14 September 202698,000$73.77SEC
31 August 2026202$72.09SEC
21 August 202660$77.18SEC
12 August 202610,465$76.45SEC
11 August 20261,196$77.49SEC
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read moreLargest in the window: 98,000 on 14 September 2026. A fail is an operational fact about settlement, not a position.

Source

Each fund's 13F-HR on EDGAR, linked per row; positions matched to CYTK by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install